Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells

[1]  V. Moravan,et al.  A competing risk analysis of colorectal cancer recurrence after curative surgery , 2022, BMC Gastroenterology.

[2]  J. Boutin,et al.  Bioactive food components for colorectal cancer prevention and treatment: A good match , 2022, Critical reviews in food science and nutrition.

[3]  R. Naidu,et al.  Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer , 2022, International journal of molecular sciences.

[4]  S. Manalis,et al.  Nucleotide imbalance decouples cell growth from cell proliferation , 2021, Nature Cell Biology.

[5]  M. Kumar,et al.  Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer , 2021, Frontiers in Molecular Biosciences.

[6]  D. Maysinger,et al.  Human astrocytes and astrocytoma respond differently to resveratrol. , 2021, Nanomedicine : nanotechnology, biology, and medicine.

[7]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[8]  M. Montopoli,et al.  Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives , 2021, International journal of molecular sciences.

[9]  S. Burma,et al.  Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells , 2020, PLoS genetics.

[10]  Zhong-Ru Xie,et al.  Elucidating the Inhibitory Effect of Resveratrol and Its Structural Analogs on Selected Nucleotide-Related Enzymes , 2020, Biomolecules.

[11]  M. Tyers,et al.  Genome-Wide Screens Reveal that Resveratrol Induces Replicative Stress in Human Cells. , 2020, Molecular cell.

[12]  Gheyath K Nasrallah,et al.  Potential Adverse Effects of Resveratrol: A Literature Review , 2020, International journal of molecular sciences.

[13]  R. Gan,et al.  Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review , 2020, Foods.

[14]  S. Krishnan,et al.  Enhancing Colorectal Cancer Radiation Therapy Efficacy using Silver Nanoprisms Decorated with Graphene as Radiosensitizers , 2019, Scientific Reports.

[15]  Wei Zhang,et al.  Investigation into perturbed nucleoside metabolism and cell cycle for elucidating the cytotoxicity effect of resveratrol on human lung adenocarcinoma epithelial cells. , 2019, Chinese journal of natural medicines.

[16]  S. Dabernat,et al.  Combination treatment of resveratrol and capsaicin radiosensitizes pancreatic tumor cells by unbalancing DNA repair response to radiotherapy towards cell death. , 2019, Cancer letters.

[17]  Pramod C. Nair,et al.  The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms. , 2019, Physiological reviews.

[18]  A. Rauf,et al.  Resveratrol as an anti-cancer agent: A review , 2018, Critical reviews in food science and nutrition.

[19]  Yuejun Kang,et al.  Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer. , 2018, ACS nano.

[20]  R. Lothe,et al.  Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies , 2017, Molecular Cancer.

[21]  Ran Elkon,et al.  Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation , 2017, Cell.

[22]  S. Dabernat,et al.  Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model. , 2017, Cancer letters.

[23]  P. Roca,et al.  Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells. , 2017, Biochimica et biophysica acta. General subjects.

[24]  A. Ali,et al.  Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity , 2016, Scientific Reports.

[25]  Zhen Zhang,et al.  Radiosensitization of Human Colorectal Cancer Cells by MLN4924 , 2016, Technology in cancer research & treatment.

[26]  M. Bronner,et al.  Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype , 2016, Cancer Prevention Research.

[27]  S. Ryu,et al.  Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition , 2016, Scientific Reports.

[28]  M. Shakibaei,et al.  Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer. , 2015, Biochemical pharmacology.

[29]  D. Delmas,et al.  Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies. , 2015, Current pharmaceutical biotechnology.

[30]  B. Daignan-Fornier,et al.  New biomarkers for early diagnosis of Lesch-Nyhan disease revealed by metabolic analysis on a large cohort of patients , 2015, Orphanet Journal of Rare Diseases.

[31]  Philippe P Roux,et al.  Regulation of global and specific mRNA translation by the mTOR signaling pathway , 2015, Translation.

[32]  Changhao Sun,et al.  Benefits and Risks of the Hormetic Effects of Dietary Isothiocyanates on Cancer Prevention , 2014, PloS one.

[33]  Dong-Hyung Cho,et al.  A nineteen gene‐based risk score classifier predicts prognosis of colorectal cancer patients , 2014, Molecular oncology.

[34]  B. Chauffert,et al.  The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models , 2014, Cell Death and Disease.

[35]  D. Hu,et al.  Transcriptional regulation of human UDP-glucuronosyltransferase genes , 2014, Drug metabolism reviews.

[36]  T. Beißbarth,et al.  UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib , 2014, Cell Death and Disease.

[37]  F. Jordan,et al.  The Pyruvate Dehydrogenase Complexes: Structure-based Function and Regulation* , 2014, The Journal of Biological Chemistry.

[38]  C. Guillemette,et al.  Evidence for regulation of UDP‐glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers , 2013, The Journal of pharmacy and pharmacology.

[39]  Yali Cui,et al.  Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  Giovanni Parmigiani,et al.  Integrating diverse genomic data using gene sets , 2011, Genome Biology.

[41]  A. Hsieh,et al.  Oncogenic AKTivation of translation as a therapeutic target , 2011, British Journal of Cancer.

[42]  E. Solary,et al.  Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. , 2011, Current medicinal chemistry.

[43]  F. Ghiringhelli,et al.  Transport, stability, and biological activity of resveratrol , 2011, Annals of the New York Academy of Sciences.

[44]  M. Mattson,et al.  Resveratrol commonly displays hormesis: Occurrence and biomedical significance , 2010, Human & experimental toxicology.

[45]  F. Liu,et al.  Resveratrol Inhibits mTOR Signaling by Promoting the Interaction between mTOR and DEPTOR* , 2010, The Journal of Biological Chemistry.

[46]  H. Bozcuk,et al.  Gene methylation of SFRP2, P16, DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal cancer. , 2010, Cancer genetics and cytogenetics.

[47]  M. Court,et al.  Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug–drug interactions between PKC inhibitors and UGT1A6 , 2010, Xenobiotica; the fate of foreign compounds in biological systems.

[48]  K. Rau,et al.  Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. , 2010, Journal of agricultural and food chemistry.

[49]  C. Guillemette,et al.  Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells , 2010, BMC Molecular Biology.

[50]  H. Saya,et al.  Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model , 2009, Cancer science.

[51]  C. Hasler,et al.  Position of the American Dietetic Association: Functional foods. , 2009, Journal of the American Dietetic Association.

[52]  V. Morsch,et al.  Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats. , 2009, Life sciences.

[53]  S. Nagar,et al.  Resveratrol (trans-Resveratrol, 3,5,4′-Trihydroxy-trans-stilbene) Glucuronidation Exhibits Atypical Enzyme Kinetics in Various Protein Sources , 2008, Drug Metabolism and Disposition.

[54]  C. Proud,et al.  When translation meets transformation: the mTOR story , 2006, Oncogene.

[55]  I. Kapetanovic,et al.  Glucuronidation of trans‐resveratrol by human liver and intestinal microsomes and UGT isoforms , 2006, The Journal of pharmacy and pharmacology.

[56]  V. Somoza,et al.  Metabolism and bioavailability of trans-resveratrol. , 2005, Molecular nutrition & food research.

[57]  P. Proksch,et al.  Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis. , 2005, The Journal of nutrition.

[58]  L. Frati,et al.  UDP-glucuronosyltransferases 1A expression in human urinary bladder and colon cancer by immunohistochemistry. , 2005, Oncology reports.

[59]  Jeffrey Cummings,et al.  Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives. , 2003, Cancer research.

[60]  I. Owens,et al.  Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase (UGT1A1) activity. , 2003, Biochemical and biophysical research communications.

[61]  J. Marier,et al.  Metabolism and Disposition of Resveratrol in Rats: Extent of Absorption, Glucuronidation, and Enterohepatic Recirculation Evidenced by a Linked-Rat Model , 2002, Journal of Pharmacology and Experimental Therapeutics.

[62]  S. Leung,et al.  Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. , 1999, Cancer research.

[63]  M. Fontecave,et al.  Resveratrol, a remarkable inhibitor of ribonucleotide reductase , 1998, FEBS letters.

[64]  M. Manns,et al.  Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. , 1997, Cancer research.

[65]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[66]  M. Chopp,et al.  Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. , 2009, Journal of experimental therapeutics & oncology.

[67]  M. Huang,et al.  Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption. , 2008, Leukemia research.

[68]  G. M. Walton,et al.  Adenosine Triphosphate Conservation in Metabolic Regulation , 2001 .

[69]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.